Alexia Savignoni

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

H. Ghesquières, Marion Chevrier, Mouna Laadhari et al. · Annals of Oncology · 2019 · 237 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer

Armelle Corpet, Leanne de Koning, Joern Toedling et al. · The EMBO Journal · 2010 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +13

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first

Marc A. Bollet, Brigitte Sigal‐Zafrani, Valérie Mazeau et al. · Radiotherapy and Oncology · 2007 · 141 citations

Medicine, Oncology, Surgery +9

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy

Youlia Kirova, Dominique Stoppa‐Lyonnet, Alexia Savignoni et al. · European Journal of Cancer · 2005 · 128 citations

Medicine, Oncology, Radiation Oncology +17

Prevalence and associated factors of sexual problems after early‐stage breast cancer treatment: results of a French exploratory survey

Anne Brédart, Sylvie Dolbeault, Alexia Savignoni et al. · Psycho-Oncology · 2010 · 120 citations

Medicine, Oncology, Breast Oncology +14